ClinicalTrials.gg
Not yet recruitingNCT07772999Updated Nov 12, 2026

Effect of Comic-Based Education on Attitudes Toward Patient Rights

An interventional study of Comic-Based Patient Rights Education and Routine Patient Rights Education in Patient Rights, sponsored by Abant Izzet Baysal University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Abant Izzet Baysal University · Not applicable, Interventional, and Health services research

Updated Nov 12, 2026Start date movedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this randomized controlled trial is to evaluate whether comic-based education improves attitudes toward the use of patient rights among adults receiving inpatient care. The main question is whether patients who receive comic-based patient rights education have more positive attitudes toward using their patient rights than patients who receive routine verbal and written patient rights education.

Participants will be randomly assigned to one of two groups. The intervention group will receive an approximately 15-minute, individual, face-to-face patient rights education session using a comic-based educational brochure. The control group will receive the hospital's routine patient rights education, consisting of verbal and written information provided by clinical nurses for approximately 15 minutes. Attitudes toward the use of patient rights will be measured before and immediately after the education in both groups.

Read the detailed description

This prospective, parallel-group randomized controlled trial will evaluate the effect of comic-based patient rights education on attitudes toward the use of patient rights among adult inpatients. Participants will be assigned to the intervention or control group using block randomization with a 1:1 allocation ratio.

Participants in the intervention group will receive a single, approximately 15-minute, individual face-to-face educational session using a comic-based patient rights brochure. The brochure was developed based on the Turkish Patient Rights Regulation and presents patient rights through visual narratives and short patient-nurse dialogues. The educational content includes access to health services, obtaining information, choosing or changing healthcare institutions and healthcare professionals, privacy, consent, access to and correction of medical records, respect and dignity, visiting and accompanying persons, respect for religious beliefs, and rights related to applications, complaints, and legal action.

Participants in the control group will receive routine patient rights education provided in the hospital. This education will be delivered individually by clinical nurses using verbal explanations and the institution's standard written educational materials and will last approximately 15 minutes.

Attitudes toward the use of patient rights will be assessed in both groups before the educational intervention and immediately after completion of the education using the Patient Rights Utilization Attitude Scale. The primary analysis will compare post-intervention scores between the groups while controlling for baseline scores.

02

Conditions studied

  • Patient Rights

Browse trials for

Keywords

  • Patient Education
  • Comic-Based Education
  • Patient Attitudes
  • Educational Brochure
  • Inpatients
  • Health Education
03

In context

Health Education

481 studies on the registry are indexed under Health Education; 110 are open to participants now.

This study's planned enrollment of 70 is below the median of 132 across 450 interventional studies indexed under Health Education.

Browse Health Education studies →

Lead sponsor

Abant Izzet Baysal University is the lead sponsor of 250 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 years or older.
  • Hospitalized in an internal medicine or surgical clinic.
  • Able to read and write in Turkish.
  • No diagnosed psychiatric disorder.
  • No visual, hearing, speech, or communication impairment that would prevent reading and understanding the educational material or completing the study questionnaires.
  • Willing to participate in the study and provide written .

Exclusion criteria

Exclusion Criteria:

  • Requiring emergency medical intervention.
  • Being hemodynamically unstable.
  • Being in a critical clinical condition.
  • Having a clinical condition that, in the judgment of the clinical team, makes participation in the educational intervention or data collection inappropriate.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Comic-Based Patient Rights Education

    Participants assigned to this arm will receive a single, individual, face-to-face patient rights education session using a comic-based educational brochure developed in accordance with the Turkish Patient Rights Regulation. The education will be delivered by the researcher and will last approximately 15 minutes. The brochure will be provided to the participant after the education.

    Behavioral: Comic-Based Patient Rights Education

  • Active comparator
    Routine Patient Rights Education

    Participants assigned to this arm will receive the hospital's routine patient rights education. The education will be provided individually by clinical nurses through verbal information supported by the institution's standard written educational materials and will last approximately 15 minutes.

    Behavioral: Routine Patient Rights Education

Interventions

  • BehavioralComic-Based Patient Rights Education

    Participants will receive a single, individual, face-to-face patient rights education session using a comic-based educational brochure developed in accordance with the Turkish Patient Rights Regulation. The education will be delivered by the researcher and will last approximately 15 minutes. The brochure presents patient rights through visual narratives and short patient-nurse dialogues and will be provided to the participant after the education.

  • BehavioralRoutine Patient Rights Education

    Participants will receive the hospital's routine patient rights education provided individually by clinical nurses. The education will consist of verbal information supported by the institution's standard written educational materials and will last approximately 15 minutes.

06

What researchers measure

Primary outcomes

  1. Post-Intervention Patient Rights Utilization Attitude Scale Score

    Attitudes toward the use of patient rights will be assessed using the Patient Rights Utilization Attitude Scale. The scale consists of 29 items rated on a 5-point Likert scale. Total scores range from 29 to 145, with higher scores indicating more positive attitudes toward using patient rights. The primary analysis will compare post-intervention scores between the intervention and control groups while adjusting for baseline scores.

    Time frame: Immediately after the approximately 15-minute educational intervention

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Nov 2026, 0 months later.

Of 292 non-industry interventional studies with no phase under Health Education, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 24. This study's planned 0 months is below that.

Counting every sponsor, half of 293 studies reached it within 11 months; a quarter within 3 and three quarters within 24.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 12, 2026: start Sep 2026 → Nov 2026, primary completion Sep 2026 → Nov 2026 and completion Oct 2026 → Nov 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 14, 2026
First posted
Aug 19, 2026
StartEst.
Nov 1, 2026was Sep 2026
Primary completionEst.
Nov 30, 2026was Sep 2026
CompletionEst.
Nov 30, 2026was Oct 2026
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Sep 1, 2026→Nov 1, 2026
Nov 12, 2026
Primary completion
Sep 30, 2026→Nov 30, 2026
Nov 12, 2026
Study completion
Oct 30, 2026→Nov 30, 2026
Nov 12, 2026
Enrollment
76→70
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    Start date Sep 1, 2026→Nov 1, 2026
    Primary completion Sep 30, 2026→Nov 30, 2026
    Study completion Oct 30, 2026→Nov 30, 2026
    Enrollment 76→70
    + 2 other changes: verification date and responsible party

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07772999
Responsible party
Lutfiye Nur Uzun (Associate Professor, Abant Izzet Baysal University) — Principal investigator
First posted
Aug 19, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Nov 30, 2026 (estimated)
Completion
Nov 30, 2026 (estimated)
Last update
Nov 12, 2026

Study contacts

Lütfiye Nur Uzun, Associate Professor
Contact
nuruzun53@gmail.com
05441088353

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion